These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of psychic energizers in general practice. DE JONG GA J Neuropsychiatr; 1961 Feb; 2 (Suppl 1)():55-7. PubMed ID: 13720552 [No Abstract] [Full Text] [Related]
3. Adjunctive use of antidepressants in a variety of medical problems. BATTERMAN RC J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():86-7. PubMed ID: 13687795 [No Abstract] [Full Text] [Related]
4. A monoamine oxidase inhibitor in the treatment of organic disease. MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597 [No Abstract] [Full Text] [Related]
5. Alpha-ethyltryptamine acetate in the treatment of depression, a study of the methodology of drug evaluation. KAST EC J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():114-8. PubMed ID: 13751710 [No Abstract] [Full Text] [Related]
9. Depression--its treatment with etryptamine acetate. SETTEL E J Am Geriatr Soc; 1961 Sep; 9():755-8. PubMed ID: 13750393 [No Abstract] [Full Text] [Related]
10. Etryptamine, a new and safer antidepressant chemical. ROBIE TR Dis Nerv Syst; 1961 Aug; 22():452-6. PubMed ID: 13742241 [No Abstract] [Full Text] [Related]
11. Treatment of geriatric patients with etryptamine acetate. KIESSLING AJ J Neuropsychiatr; 1961 Feb; 2(Suppl1)():64-5. PubMed ID: 13755873 [No Abstract] [Full Text] [Related]
12. Antidepressant medication and its use in psychiatric hospital practice. TURNER WJ; MERLIS S J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():69-72. PubMed ID: 13778758 [No Abstract] [Full Text] [Related]
13. Current trends in the use of monoamine oxidase inhibitors in depression. PRANGE AJ N C Med J; 1960 Dec; 21():546-7. PubMed ID: 13737718 [No Abstract] [Full Text] [Related]
14. Some pharmacological aspects of monoamine oxidase regulators. HORITA A J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():141-5. PubMed ID: 13715853 [No Abstract] [Full Text] [Related]
15. [Monoamine oxidase inhibitors in the treatment of depressive states]. GARRONE G; DICK P Psychiatr Neurol (Basel); 1960 Jul; 140():107-14. PubMed ID: 13703760 [No Abstract] [Full Text] [Related]
16. [Some results of the treatment of depressive states by a monoamine oxidase-inhibiting hydrazide, nialamide]. FOURNY L; SEGAL J; SEGAL A Toulouse Med; 1961 Feb; 62():137-41. PubMed ID: 13701049 [No Abstract] [Full Text] [Related]
18. [On incompatibility between monoamine oxidase inhibitors and imipramin (with remarks on the work of O. Eichhorn "Remarks on psychopharmacological combined therapy" in Wien. Med. Wschr. 111, 1961, 307)]. HARRER G Wien Med Wochenschr; 1961 Aug; 111():551-3. PubMed ID: 13711697 [No Abstract] [Full Text] [Related]
19. [The effect of monoamino oxidase inhibitor (MOI) in depression. Psychodynamics and biological reactivity]. CAZULLO CL Wien Med Wochenschr; 1960 Sep; 110():731-3. PubMed ID: 13691798 [No Abstract] [Full Text] [Related]